Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
975.18M | 766.89M | 595.34M | 425.49M | 318.79M | Gross Profit |
395.96M | 250.87M | 186.03M | 162.15M | 132.91M | EBIT |
38.00M | -30.45M | -51.98M | -24.65M | -1.91M | EBITDA |
38.00M | 41.10M | -14.35M | 7.15M | 19.21M | Net Income Common Stockholders |
46.92M | -33.61M | -55.76M | -27.69M | -3.19M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
268.63M | 296.87M | 132.74M | 72.79M | 67.25M | Total Assets |
1.57B | 1.46B | 1.13B | 784.41M | 434.39M | Total Debt |
424.09M | 425.06M | 5.71M | 7.09M | 8.40M | Net Debt |
155.46M | 128.18M | -127.03M | -65.69M | -58.85M | Total Liabilities |
519.52M | 510.97M | 93.81M | 64.66M | 40.22M | Stockholders Equity |
1.06B | 953.45M | 1.03B | 719.75M | 394.17M |
Cash Flow | Free Cash Flow | |||
154.29M | -163.15M | -273.30M | -321.45M | -113.38M | Operating Cash Flow |
154.29M | 75.94M | -43.23M | 647.00K | 21.19M | Investing Cash Flow |
-187.09M | -239.09M | -233.36M | -322.10M | -162.46M | Financing Cash Flow |
4.57M | 327.29M | 336.54M | 326.99M | 199.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $3.69B | 26.08 | 7.99% | ― | 9.07% | 5.85% | |
75 Outperform | $6.36B | 18.95 | 10.08% | ― | 7.32% | 34.44% | |
72 Outperform | $14.33B | 38.71 | 28.79% | ― | 12.90% | 50.20% | |
64 Neutral | $4.61B | 101.47 | 4.45% | ― | 27.16% | ― | |
63 Neutral | $20.85B | 13.27 | -10.88% | 7.48% | 1.13% | 11.50% | |
44 Neutral | $342.04M | ― | -21.72% | ― | -6.68% | -9.71% | |
39 Underperform | $37.34M | ― | 31.02% | ― | -11.65% | -174.54% |
Freshpet reported significant financial progress for the fourth quarter and full year 2024, with net sales increasing by 22% and 27.2% respectively, compared to the prior year. The company achieved positive net income for the first time, driven by improved gross margins and operational efficiencies. Freshpet also provided a positive outlook for 2025, projecting further sales growth and increased profitability, reflecting its strategic focus on transforming the pet food category and enhancing shareholder value.
Freshpet, Inc. has announced the approval of 2025 Retention Grants for three key executives, including the CEO, President and Co-Founder, and Chief Human Resources Officer, in the form of Restricted Stock Units (RSUs). The grants aim to retain these executives, deemed critical for the company’s value creation, and ensure future growth. These grants include both time-based and performance-based vesting conditions, with specific financial goals tied to the company’s net sales and Adjusted EBITDA margin over a three-year period, encouraging sustained performance and alignment with shareholder interests.